Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 6389157, 10 pages
https://doi.org/10.1155/2018/6389157
Review Article

Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan

1Division of Oral Bioengineering, Institute of Medicine and Dentistry, Niigata University, Niigata 951-8514, Japan
2Division of Periodontology, Institute of Medicine and Dentistry, Niigata University, Niigata 951-8514, Japan

Correspondence should be addressed to Tomoyuki Kawase; pj.ca.u-atagiin.tned@esawak

Received 15 January 2018; Accepted 2 April 2018; Published 21 May 2018

Academic Editor: Elena Jones

Copyright © 2018 Tomoyuki Kawase and Kazuhiro Okuda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Sánchez, A. Garate, D. Delgado, and S. Padilla, “Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair,” Neural Regeneration Research, vol. 12, no. 1, pp. 47–52, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Dhillon, E. M. Schwarz, and M. D. Maloney, “Platelet-rich plasma therapy—future or trend?” Arthritis Research & Therapy, vol. 14, no. 4, p. 219, 2012. View at Publisher · View at Google Scholar
  3. K. Beitzel, D. Allen, J. Apostolakos et al., “US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine,” The Journal of Knee Surgery, vol. 28, no. 1, pp. 29–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Fiorentino, A. Roffi, G. Filardo, M. Marcacci, and E. Kon, “European definitions, current use, and EMA stance of platelet-rich plasma in sports medicine,” The Journal of Knee Surgery, vol. 28, no. 1, pp. 51–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Anitua, R. Prado, and G. Orive, “Closing regulatory gaps: New ground rules for platelet-rich plasma,” Trends in Biotechnology, vol. 33, no. 9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Anitua, R. Prado, and G. Orive, “A New Regulatory Framework for Platelet-Rich Plasma in Spain,” Journal of Knee Surgery, vol. 28, no. 4, pp. 355-356, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Konomi, M. Tobita, K. Kimura, and D. Sato, “New Japanese initiatives on stem cell therapies,” Cell Stem Cell, vol. 16, no. 4, pp. 350–352, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. “The Ministry of Health Labour and Welfare of Japan, "Regenerative Medicine,",” 2018, http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryou/saisei_iryou/.
  9. “The Ministry of Health Labour and Welfare of Japan, "Guidance of the Act on Securement of Safety of Regenerative Medicine,” 2018, http://www.mhlw.go.jp/file/06-Seisakujouhou-10800000-Iseikyoku/0000079192.pdf.
  10. H. Okura and A. Matsuyama, “History of development and regulations for regenerative medicines in Japan,” Journal of Stem Cell Research & Therapy, vol. 07, no. 01, 2017. View at Publisher · View at Google Scholar
  11. M. Tobita, K. Konomi, Y. Torashima, K. Kimura, M. Taoka, and M. Kaminota, “Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine,” Regenerative Therapy, vol. 4, pp. 78–81, 2016. View at Publisher · View at Google Scholar
  12. C. A. Herberts, M. S. G. Kwa, and H. P. H. Hermsen, “Risk factors in the development of stem cell therapy,” Journal of Translational Medicine, vol. 9, article 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Haddock, S. Lin-Gibson, and N. Lumelsky, Manufacturing Cell Therapies: The Paradigm Shift in Health Care of This Century, URL https, 2018, https://nam.edu/wp-content/uploads/2017/06/Manufacturing-Cell-Therapies.pdf.
  14. N. Metcalf, P. Hourd, and A. Chandra, Quality assurance and GMP in the manufacture of cell-based therapeutics, 2013.
  15. J. Carmen, S. R. Burger, M. McCaman, and J. A. Rowley, “Developing assays to address identity, potency, purity and safety: Cell characterization in cell therapy process development,” Journal of Regenerative Medicine, vol. 7, no. 1, pp. 85–100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. K. Gavin, Advanced Topics: Successful Development of Quality Cell and Gene Therapy Products, 2018, 2018, https://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/UCM251337.pdf.
  17. M. R. De Pascale, L. Sommese, A. Casamassimi, and C. Napoli, “Platelet derivatives in regenerative medicine: an update,” Transfusion Medicine Reviews, vol. 29, no. 1, pp. 52–61, 2015. View at Publisher · View at Google Scholar
  18. J. Margolis, “Glass surface and blood coagulation [14],” Nature, vol. 178, no. 4537, pp. 805-806, 1956. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Alsousou, A. Ali, K. Willett, and P. Harrison, “The role of platelet-rich plasma in tissue regeneration,” Platelets, vol. 24, no. 3, pp. 173–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Isobe, T. Watanebe, H. Kawabata et al., “Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF),” International Journal of Implant Dentistry, vol. 3, no. 1, 2017. View at Publisher · View at Google Scholar
  21. K. Okuda, T. Kawase, M. Momose et al., “Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-β and modulates the proliferation of periodontally related cells in vitro,” Journal of Periodontology, vol. 74, no. 6, pp. 849–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Kitamura, T. Watanabe, M. Nakamura et al., “Platelet Counts in Insoluble Platelet-Rich Fibrin Clots: A Direct Method for Accurate Determination,” Frontiers in Bioengineering and Biotechnology, vol. 6, no. 4, 2018. View at Publisher · View at Google Scholar
  23. L. F. Marques, T. Stessuk, I. C. C. Camargo, N. Sabeh Junior, L. D. Santos, and J. T. Ribeiro-Paes, “Platelet-rich plasma (PRP): Methodological aspects and clinical applications,” Platelets, vol. 26, no. 2, pp. 101–113, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Mosca and S. A. Rodeo, “Platelet-rich plasma for muscle injuries: game over or time out?” Current Reviews in Musculoskeletal Medicine, vol. 8, no. 2, pp. 145–153, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Roffi, G. Filardo, E. Kon, and M. Marcacci, “Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review,” BMC Musculoskeletal Disorders, vol. 14, article 330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Szczeklik, J. Musiał, A. Undas et al., “Aspirin and thrombinogenesis,” Thrombosis Research, vol. 110, no. 5-6, pp. 345–347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Tadros and S. Shakib, “Warfarin: Indications, risks and drug interactions,” Australian Family Physician, vol. 39, no. 7, pp. 476–479, 2010. View at Google Scholar · View at Scopus
  28. D. Wardrop and D. Keeling, “The story of the discovery of heparin and warfarin,” British Journal of Haematology, vol. 141, no. 6, pp. 757–763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Schrör, “Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis,” Seminars in Thrombosis and Hemostasis, vol. 23, no. 4, pp. 349–356, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. H. Kim, H. Y. Bae, and S. Y. Kim, “Clinical marker of platelet hyperreactivity in diabetes mellitus,” Diabetes & Metabolism, vol. 37, no. 6, pp. 423–428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Kubisz, L. Stanciaková, J. Staško, P. Galajda, and M. Mokáň, “Endothelial and platelet markers in diabetes mellitus type 2,” World Journal of Diabetes, vol. 6, no. 3, pp. 423–431, 2015. View at Publisher · View at Google Scholar
  32. B. J. McEwen, “The influence of diet and nutrients on platelet function,” Seminars in Thrombosis and Hemostasis, vol. 40, no. 2, pp. 214–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Rajaram, “The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis,” American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 552S–558S, 2003. View at Publisher · View at Google Scholar
  34. G. Grignani, L. Pacchiarini, M. Zucchella et al., “Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease,” Pathophysiology of Haemostasis and Thrombosis, vol. 22, no. 3, pp. 138–146, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. N. H. Wallen, C. Held, N. Rehnqvist, and P. Hjemdahl, “Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls,” European Heart Journal, vol. 18, no. 5, pp. 807–815, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Naesh, J. T. Friis, and I. Hindberg, “Platelet function in surgical stress,” Thrombosis and Haemostasis, vol. 54, pp. 849–852, 1985. View at Google Scholar
  37. P. Koudouovoh-Tripp, “Influence of mental stress on platelet bioactivity,” World Journal of Psychiatry, vol. 2, no. 6, p. 134, 2012. View at Publisher · View at Google Scholar
  38. D. J. O'Keeffe and T. P. Baglin, “Travellers' thrombosis and economy class syndrome: Incidence, aetiology and prevention,” Clinical & Laboratory Haematology, vol. 25, no. 5, pp. 277–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Graziani, S. Ivanovski, S. Cei, F. Ducci, M. Tonetti, and M. Gabriele, “The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts,” Clinical Oral Implants Research, vol. 17, no. 2, pp. 212–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Masuki, T. Okudera, T. Watanebe et al., “Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF),” International Journal of Implant Dentistry, vol. 2, no. 1, 2016. View at Publisher · View at Google Scholar
  41. M. Nagata, H. Hoshina, M. Li et al., “A clinical study of alveolar bone tissue engineering with cultured autogenous periosteal cells: coordinated activation of bone formation and resorption,” Bone, vol. 50, no. 5, pp. 1123–1129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Ogawa, H. Hoshina, K. Nakata et al., “High-Resolution Three-Dimensional Computed Tomography Analysis of the Clinical Efficacy of Cultured Autogenous Periosteal Cells in Sinus Lift Bone Grafting,” Clinical Implant Dentistry and Related Research, vol. 18, no. 4, pp. 707–716, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Kobayashi, T. Kawase, M. Horimizu, K. Okuda, L. F. Wolff, and H. Yoshie, “A proposed protocol for the standardized preparation of PRF membranes for clinical use,” Biologicals, vol. 40, no. 5, pp. 323–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Kawase, “Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances,” Odontology, vol. 103, no. 2, pp. 126–135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Sampson, M. Gerhardt, and B. Mandelbaum, “Platelet rich plasma injection grafts for musculoskeletal injuries: a review,” Ethics in Science and Environmental Politics, vol. 1, no. 3-4, pp. 165–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Kawase and T. Tanaka, “An updated proposal for terminology and classification of platelet-rich fibrin,” Regenerative Therapy, vol. 7, pp. 80-81, 2017. View at Publisher · View at Google Scholar